Atlas Trials

To Identify the Immunogenicity and Safety of QIV in Children Aged 3-8 Years

Clinical trial NCT05389137 · UNKNOWN

Trial details

NCT number
NCT05389137
Sponsor
Wuhan Institute of Biological Products Co., Ltd
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Influenza
Start date
2022-03-02
Primary completion
2022-05-01
Enrollment
360

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.